FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Akorn Myorisan Recall

Myorisan (isotretinoin capsules, USP), 40 mg, packaged in cartons of 30 Capsules contai…

Akorn Inc · Lake Forest, IL

Risk level
Class III
Reported by FDA
Jun 26, 2019
Recall ID
D-1392-2019
Check your lot numberHow we source this data

Summary

Akorn recalled Myorisan starting Jun 7, 2019. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1392-2019 on Jun 26, 2019. Reason: Labeling: Label mix-up: Product secondary carton erroneously states 40mg instead of 30 mg, primary carton is label correctly. Status: Terminated.

Why it was recalled

Labeling: Label mix-up: Product secondary carton erroneously states 40mg instead of 30 mg, primary carton is label correctly.

Product description

Myorisan (isotretinoin capsules, USP), 40 mg, packaged in cartons of 30 Capsules containing 3 x 10 Prescription Packs, Rx Only, Distributed by: VersaPharm Inc. - An Akorn Company, Lake Forest, IL 60045, NDC 61748-304-13

Lot numbers, UPCs & expiration codes

Lot#: V30M56A, Exp 9/20

Where it was sold

Nationwide USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1392-2019
Classification
Class III
Status
Terminated
Recall initiated
Jun 7, 2019
FDA report date
Jun 26, 2019
Quantity
16,216 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Akorn Inc

Original FDA data

Every field from FDA enforcement report D-1392-2019, exactly as published.

Show all FDA fields
City
Lake Forest
State
IL
Status
Terminated
Country
United States
Event ID
83073
Address
1925 W Field Ct Ste 300
Code information
Lot#: V30M56A, Exp 9/20
Postal code
60045-4862
Report date
Jun 26, 2019
Product type
Drugs
Recall number
D-1392-2019
Classification
Class III
Recalling firm
Akorn Inc
Product quantity
16,216 cartons
Termination date
Jul 28, 2022
Reason for recall
Labeling: Label mix-up: Product secondary carton erroneously states 40mg instead of 30 mg, primary carton is label correctly.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Myorisan (isotretinoin capsules, USP), 40 mg, packaged in cartons of 30 Capsules containing 3 x 10 Prescription Packs, Rx Only, Distributed by: VersaPharm Inc. - An Akorn Company, Lake Forest, IL 60045, NDC 61748-304-13
Distribution pattern
Nationwide USA
Recall initiation date
Jun 7, 2019
Initial firm notification
Letter
Center classification date
Jun 17, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1392-2019, published Jun 26, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls